Sinai Health System
Posted Tuesday, January 17, 2017

C:\Users\sparrott\Desktop\Dr  Catherine VarnerJanuary 17, 2017 (Toronto, ON) – A new Sinai Health System study demonstrates there is no difference in symptoms or recovery times between patients who received standard post-concussion discharge instructions developed by the Centre for Disease Control and those who did not. The findings indicate that the current post-concussion protocols given to patients may need to be reconsidered. The study, published in Academic Emergency Medicine, was led by Dr. Catherine Varner,...
Read More...

Posted Thursday, January 12, 2017

C:\Users\mpubd1m\Desktop\SALLY\blood-pressure-200x185A new paper published in the American Journal of Hypertension suggests that a woman’s blood pressure before pregnancy is related to her likelihood of giving birth to a boy or girl.
The possibility of predicting the sex of the baby in early pregnancy has long been a topic of public fascination, spawning numerous theories of maternal characteristics associated with the presence of a male or female fetus, none of which has been conclusively supported by robust scientific...

Read More...

Posted Wednesday, January 11, 2017

Visiting a patient? Please don’t bring the flu or other viruses with you. Please take the time to get the facts about the flu before visiting. Read more

Read More...

Posted Tuesday, January 10, 2017

The Centre for Phenogenomics (TCP) , a world class facility that develops mouse models of human diseases, has been awarded a grant of $15.41 million over the next 5 years from the Canada Foundation for Innovation . TCP is jointly operated by Mount Sinai Hospital ’s Lunenfeld-Tanenbaum Research Institute and the Research Institute of The Hospital for Sick Children and is Canada’s preeminent research facility for design, generation, and analysis of models of disease...
Read More...

Posted Monday, December 19, 2016

Over the past decade, there has been enormous progress in understanding the effect of genes on autism spectrum disorder (ASD). Indeed, through DNA sequencing technologies, a substantive list of genes that are associated with the disorder has been constructed. However, the vast majority of these affect a very small number of people. This presents a challenge in developing possible therapeutics. That may be about to change via a new study in mice by two teams of Toronto researchers...
Read More...